A Relative Bioavailability Study With a Novel PanCytoVir™ Oral Suspension (100 mg/ml)

Clinical trial NCT06025344 · COMPLETED

Trial details

NCT number: NCT06025344
Sponsor: TrippBio, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relative Bioavailability

Start date: 2024-09-01
Primary completion: 2024-09-30
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.